Commiphora mukul gum extract
Amsar’s guugul extract is based on the original research conducted by CDRI and conforms to the IP Pharmacopoeia standards. The lipid lowering effect of guggulu with special reference to atherosclerosis and obesity (medoraga) was first reported in a doctorate thesis submitted to the Banaras Hindu University (BHU) in January 1966. Gugulipid, an ethyl acetate extract of the oleoresin, standardized at CDRI, has been marketed in India since 1988 as a hypolipidemic agent. It contains -guggulsterones and -guggulsterones which are purported to be the compounds responsible for the hypolipidemic activity of the guggulu. The extract is produced in our GMP certified facility.